These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10182972)

  • 21. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
    Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
    Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer prevention: present and future.
    Salih AK; Fentiman IS
    Cancer Treat Rev; 2001 Oct; 27(5):261-73. PubMed ID: 11871862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent results from clinical trials using SERMs to reduce the risk of breast cancer.
    Vogel VG
    Ann N Y Acad Sci; 2006 Nov; 1089():127-42. PubMed ID: 17261762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trials 'must compete for new funds'.
    Gavaghan H
    Nature; 1994 Jun; 369(6482):597. PubMed ID: 8208276
    [No Abstract]   [Full Text] [Related]  

  • 26. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NCI's transition plan for participants in women's health trial.
    Oncology (Williston Park); 1988 Dec; 2(12):36. PubMed ID: 3079290
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast cancer activism: the birth of a movement.
    Fintor L
    Healthspan; 1991; 8(7):11-4. PubMed ID: 10114027
    [No Abstract]   [Full Text] [Related]  

  • 29. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing avoidable cancer mortality through prevention and early detection regimens.
    Lerman C; Rimer B; Engstrom PF
    Cancer Res; 1989 Sep; 49(18):4955-62. PubMed ID: 2766269
    [No Abstract]   [Full Text] [Related]  

  • 31. Keeping breast cancer at bay. Women at risk are asked to weigh the pros and cons of a prevention pill.
    Brink S
    US News World Rep; 1999 May; 126(21):76. PubMed ID: 10387894
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
    Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
    J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New approaches to the endocrine prevention and treatment of breast cancer.
    Howell A; Howell SJ; Evans DG
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S39-44. PubMed ID: 12819938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Breast Cancer Continuum: insights from the tamoxifen trials impact future drug development strategies.
    Lewis JP
    Ann N Y Acad Sci; 2001 Dec; 949():327-32. PubMed ID: 11795371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NCI's breast cancer clinical alert: rationale and results.
    DeVita VT; Hubbard SM
    Resid Staff Physician; 1989 Jul; 35(8):49-55. PubMed ID: 10303742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fat intake and breast cancer revisited.
    Smith-Warner SA; Stampfer MJ
    J Natl Cancer Inst; 2007 Mar; 99(6):418-9. PubMed ID: 17374825
    [No Abstract]   [Full Text] [Related]  

  • 38. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):1-2, 5. PubMed ID: 12518771
    [No Abstract]   [Full Text] [Related]  

  • 39. Raloxifene (Evista) for breast cancer prevention in postmenopausal women.
    Med Lett Drugs Ther; 2006 May; 48(1234):37. PubMed ID: 16685245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
    Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.